ANGPT1 and ischemic stroke: In addition to Ang (1–7) treatment, gene-engineered mice overexpressing ACE2 in neurons revealed a reduction in the levels of Nox2/Nox4 [43] and subsequent alleviation of ROS production after ischemic stroke [21] possibly through inhibition of microglial activation in cerebral cortex [21,25].